MASSIVE GAINS

[Golden Cross]

MGON Confirmed .078 EBITDA Valuation...

Original post by stervc

This is very solid news for MGON that justifies a value of .078 per share based on EBITDA as explained below:

Quote:

https://ih.advfn.com/p.php?pid=nmona&article=78592380
Houston, Texas, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Publicly-held Megola, Inc. (OTC Pink: MGON) is
pleased to announce current status of revenues and future direction of sales distributions into
the United States and Canadian CBD (Cannabidiol) markets. Acordy President Francisco Baez states:
“For 2018, the Company is rapidly approaching 2 million euros ($2.4 million US Dollars) in revenues.
This reflects an increase of over 300% compared with the same nine month period of 2017. Pretax profits
for the nine months ending 9-30-2018 came in at €490,524 (approximately USD$ 585,000) representing
nearly a 200 % increase over 2017. With Megola introducing CBD products and CBD infused olive oil into
the U.S. and Canada, we are poised for substantial growth in 2019”.


Below is a Gross Valuation Based on EBITDA:

Gross Income ÷ Outstanding Shares (OS) = Earnings Per Share (EPS)
EPS x Price to Earnings (PE) Ratio = MGON Share Price Valuation

$585,000 per 9 months = $65,000 Per Month Per Year
$65,000 x 12 = $780,000 Gross Profit Per Year

$780,000 ÷ 196,095,060 Shares (MGON OS) = .0039 EPS

.0039 EPS x 20 PE Ratio = .078 MGON Share Price Valuation EBITDA

The 20 used is what is believed is a fair and conservative Price to Earnings (PE) Ratio as the
growth rate for the Marijuana Industry.

Also, this does not take into account any future growth that is planned by the company which
leads one to believe that MGON is significantly undervalued. More info about Acordy is below:


https://twitter.com/MegolaMMJ


http://www.acordyinvest.com/